Cefazolin-Induced Neutropenia Development and Evaluation of Risk Factors in Home Infusion (CINDER-FHI)
Infusion Journal · 2023
DOI: 10.70776/qghn7911 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infusion Journal, 2023. Verfasst von Nicholas Panchak und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Beta-lactam-induced neutropenia (BLIN) is a serious adverse reaction associated with extended treatment courses. For many severe infections, guideline-directed medical therapy frequently involves weeks or months of IV antibiotics. To avoid health care costs associated with hospitalization and as a method to improve hospital bed capacity, clinicians are encouraged to discharge patients to receive IV antibiotics in the ambulatory setting once clinically stable. The purpose of this study was to compare the incidence of cefazolin-induced neutropenia between intravenous push (IVP) administration and intermittent infusions among home infusion patients. This study is unique in its analysis of neutropenia monitoring and interventions in a pharmacist-led outpatient parenteral anti-infective therapy (OPAT) model. Cefazolin was examined over other beta-lactams due to high utilization in home infusion and administration methods by IVP and intermittent infusion at this institution.
Methods
This was a retrospective cohort study within a single large health system that includes an associated home infusion pharmacy. Patients were included for analysis if they met the following criteria: ≥18 years of age, received cefazolin through the home infusion pharmacy between July 1, 2017, and July 1, 2022, and were discharged from an acute care site within the health system for index cefazolin episode to the home or an affiliated long-term care facility. Lab values within 2 weeks of the cefazolin treatment course were evaluated for neutropenia. The primary outcome was the incidence of neutropenia by the method of administration: IVP versus intermittent infusion. Patients who received intermittent infusions in this study utilized elastomeric devices or ambulatory infusion pumps. Duration of IVP and intermittent infusion were defined as being given over 10 minutes and 30 minutes, respectively.
Results
A total of 431 patients were included in the study. Home infusion pharmacists recorded 18 BLIN events. All patients were asymptomatic. Fourteen events were classified as mild, with an absolute neutrophil count (ANC) nadir of 1.1-1.5 cells×1000/μL. Two events were considered moderate and 2 were considered severe, with ANC nadirs between 0.5 to 1.0 cells×103/μL and
Zitieren
APA
Panchak, N., McFarland, R., Das, J., Zagel, A., & Ross, J. (2023). Cefazolin-Induced Neutropenia Development and Evaluation of Risk Factors in Home Infusion (CINDER-FHI). Infusion Journal. https://doi.org/10.70776/qghn7911
Vancouver
Panchak N, McFarland R, Das J, Zagel A, Ross J. Cefazolin-Induced Neutropenia Development and Evaluation of Risk Factors in Home Infusion (CINDER-FHI). Infusion Journal. 2023. doi:10.70776/qghn7911
BibTeX
@article{Panchak2023,
author = {Panchak, Nicholas and McFarland, Ryan and Das, Jessica and Zagel, Alicia and Ross, Jennifer},
title = {Cefazolin-Induced Neutropenia Development and Evaluation of Risk Factors in Home Infusion (CINDER-FHI)},
journal = {Infusion Journal},
year = {2023},
doi = {10.70776/qghn7911}
}
EUVIMED